[The good use of drugs derived from blood].
Rational use of blood-derived products should only be viewed in close collaboration with haemostasis laboratory teams, pharmacists and transfusion centers. The crucial role of a detailed clinical interview can never be emphasized enough. The use of blood-derived products or the elaboration of new therapeutic strategies should always be mentioned in a written protocol. These procedures clearly belong to quality control implementation. The patient as well as the surgical team should always be aware of haemostasis procedures.